Clincosm LogoSign in Get a demo

Tuberculosis, Multidrug-Resistant

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Strengthening Evidence on Optimal Multidrug-resistant

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • HIV
  • Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
  • +2 more
  • Almaty, Kazakhstan
  • +2 more
May 12, 2023

Clinical Evaluation of tNGS for Diagnosis of DR-TB

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • targeted Next Generation Sequencing (tNGS)
  • Tbilisi, Georgia
  • +2 more
Jan 23, 2023

Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Linezolid 600 mg
  • +7 more
  • Gaborone, South-East District, Botswana
  • +16 more
Dec 13, 2022

Tuberculosis, Multidrug-Resistant Trial (Amikacin)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • (no location specified)
Sep 23, 2022

Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)

Active, not recruiting
  • Tuberculosis
  • +3 more
  • therapeutical surgery for TB
  • Tbilisi, Georgia
    National Center for Tuberculosis and Lung Diseases
Sep 9, 2022

Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • Dasmariñas, Philippines
  • +1 more
Jun 21, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Expand New Drugs for TB [endTB]

Completed
  • Tuberculosis, Multidrug-Resistant
  • This is a non-intervention observational study
  • Abovyan, Armenia
  • +15 more
Jun 9, 2022

Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation

Recruiting
  • Tuberculosis, Multidrug-Resistant
    • Nairobi, Kenya
    • +2 more
    Mar 16, 2022

    Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

    Recruiting
    • Tuberculosis, Multidrug-Resistant
    • +5 more
    • Bedaquiline 100 MG
    • +4 more
    • Pune, India
    • +9 more
    Mar 2, 2022

    Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

    Active, not recruiting
    • Tuberculosis, Multidrug-Resistant
    • +2 more
    • Tbilisi, Georgia
    • +11 more
    Feb 14, 2022

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

    Active, not recruiting
    • Tuberculosis, Pulmonary
    • +5 more
    • Tbilisi, Georgia
    • +10 more
    Jan 26, 2022

    Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)

    Completed
    Has Results
    • Tuberculosis, Multidrug-Resistant
    • Beijing, China
    • +7 more
    Sep 30, 2021

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

    Recruiting
    • Tuberculosis, Pulmonary
    • +4 more
    • Johannesburg, South Africa
    • +2 more
    Oct 4, 2021

    Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)

    Not yet recruiting
    • Tuberculosis, Multidrug-Resistant
    • Targeted sequencing using the GenoScreen Deeplex assay
    • Cape Town, Western Cape, South Africa
      University of Cape Town
    Sep 28, 2021

    Hotspots, Households and Hospitals: Enhanced Drug-resistant

    Not yet recruiting
    • Tuberculosis, Multidrug-Resistant
      • (no location specified)
      Aug 19, 2021

      Xpert MTB/XDR Clinical Evaluation Trial

      Completed
      • Tuberculosis, Pulmonary
      • Tuberculosis, Multidrug-Resistant
      • Cepheid Gene Xpert MTB/XDR
      • Chisinau, Moldova, Republic of
        Institute of Pthisiopenumology
      May 17, 2021

      Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

      Active, not recruiting
      • Tuberculosis, Multidrug-Resistant
      • +2 more
      • Minsk, Belarus
      • +6 more
      May 12, 2021

      Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Bacterial Infections Trial in Worldwide (Individualised treatment

      Recruiting
      • Tuberculosis, Pulmonary
      • +3 more
      • Individualised treatment duration based on RNA transcriptomic model
      • Borstel, Schleswig-Holstein, Germany
      • +4 more
      Apr 7, 2021

      Tuberculosis, Multidrug-Resistant Trial in Kiyose, Sakai (TMC207 (bedaquiline), Background Regimen (BR))

      Completed
      • Tuberculosis, Multidrug-Resistant
      • TMC207 (bedaquiline)
      • Background Regimen (BR)
      • Kiyose, Japan
      • +1 more
      Oct 30, 2019

      Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

      Unknown status
      • Tuberculosis, Multidrug-Resistant
      • Centralized Therapeutic Drug Monitoring
      • Brisbane, Australia
      • +12 more
      Oct 8, 2019

      Biomarkers for Therapy Response in Drug-resistant Tuberculosis

      Unknown status
      • Tuberculosis, Multidrug-resistant
      • no intervention
      • Borstel, Schleswig-Holstein, Germany
        Research Center Borstel
      Sep 20, 2019

      Nosocomial Transmission of MDR-TB in Bucharest, Romania

      Unknown status
      • Tuberculosis, Multidrug-resistant
      • Routine management practices applied
      • Bucharest, Romania
        Marius Nasta Pulmonology Institute
      Sep 20, 2019

      Tuberculosis, Multidrug-Resistant Trial in Seoul (Linezolid, Delamanid, Levofloxacin)

      Unknown status
      • Tuberculosis, Multidrug-Resistant
      • Seoul, Korea, Republic of
        Division of Pulmonology and Critical Care Medicine, Department o
      Jan 31, 2019

      Tuberculosis in China

      Completed
      • Tuberculosis
      • +2 more
        • Zhengzhou, China
          Henan Provincial Chest Hospital
        Apr 4, 2018